News

Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign

CAMBRIDGE, MA / ACCESSWIRE / April 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a contract with the Ministry of…

2 years ago

Simple HealthKit Expands Access to At-Home Diagnostics and Follow-up Care for Diabetes, Respiratory Wellness and Sexual Wellness with Product Launch in Amazon’s U.S. Store

Created by people who believe world-class care is a right, not a privilege, Simple HealthKit addresses high-need and high-impact health…

2 years ago

Aeroflow Health Celebrates the Success of Nebraska’s Passage of Bill LB1215, Featuring Provisions to Include Access to Products & Services for Expecting and New Mothers

The national durable medical equipment provider was active in achieving the necessary provisions in Bill L1215 to increase access to…

2 years ago

VIVUS Announces it will Provide Telehealth to Patients through an Enhanced ‘Engage’ Program in Collaboration with UpScriptHealth

Collaboration will deliver a seamless telehealth experience, providing patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing…

2 years ago

Cidara Therapeutics Announces Reverse Stock Split

SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its…

2 years ago

ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients

Interim readout of 22 patients shows unprecedented efficacy data compared to prior atopic dermatitis (AD) studies with biologics: 60.0% of…

2 years ago

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,…

2 years ago

Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market

Raised gross proceeds of $59 million through the issuance and sale of 5,000,000 of its ordinary shares to Icelandic institutional…

2 years ago

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage…

2 years ago

Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters

Selective CVN293 may have treatment potential in multiple neurodegenerative conditionsBOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused…

2 years ago